CB-10-YX20_10uM Gene Set

Dataset NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles
Category transcriptomics
Type drug perturbation
Description Dose=10uM, 2-(2-Phenylethenyl)-4-(pyridin-3-ylmethylidene)-4,5-dihydro-1,3-oxazol-5-one, DAPK1/3 inhibitor targeting DAPK1 (Novartis, 2360773)
External Link https://pubchem.ncbi.nlm.nih.gov/compound/2360773
Similar Terms
Downloads & Tools

Genes

14 genes differentially expressed following the CB-10-YX20_10uM drug perturbation from the NIBR DRUG-seq U2OS MoA Box dataset.

increased expression

Symbol Name Standardized Value
FAU Finkel-Biskis-Reilly murine sarcoma virus (FBR-MuSV) ubiquitously expressed 0.497231
NDUFS7 NADH dehydrogenase (ubiquinone) Fe-S protein 7, 20kDa (NADH-coenzyme Q reductase) 0.497231
RPL28 ribosomal protein L28 0.482123
OAZ1 ornithine decarboxylase antizyme 1 0.470429
UBC ubiquitin C 0.362418
GAPDH glyceraldehyde-3-phosphate dehydrogenase 0.337065
RPL18A ribosomal protein L18a 0.312087
TRAP1 TNF receptor-associated protein 1 0.295289
PSMB3 proteasome (prosome, macropain) subunit, beta type, 3 0.264234
RPL38 ribosomal protein L38 0.235955
NDUFS8 NADH dehydrogenase (ubiquinone) Fe-S protein 8, 23kDa (NADH-coenzyme Q reductase) 0.202882
MT1E metallothionein 1E 0.202882

decreased expression

Symbol Name Standardized Value
NCOA6 nuclear receptor coactivator 6 -0.235923
POTEF POTE ankyrin domain family, member F -0.205173